If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptima Health Regulatory News (OPT)

Share Price Information for Optima Health (OPT)

Share Price is delayed by 15 minutes
Get Live Data
191.00    0.00 (0.00%)
Bid:
190.00
Ask:
192.00
Spread: 2.00 (1.053%)
Market Cap: £207.76m
OPT Live PriceLast checked at - London Stock Exchange

Intraday Optima Health Share Chart

Full Year Trading Update

17 Apr 2026 07:00

RNS Number : 9162A
Optima Health PLC
17 April 2026
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

17 April 2026

Optima Health plc

("Optima", the "Company", and, together with its subsidiaries, the "Group")

Full Year Trading Update

Full year adjusted EBITDA expected to be c.10% ahead of market expectations

Optima Health (AIM: OPT), the UK's leading provider of technology enabled corporate health and wellbeing solutions, today announces an unaudited trading update for the year ended 31 March 2026.

Further to the previously communicated commentary on current trading announced on 31 March 2026, Optima now expects FY26 Adjusted EBITDA to be ahead of market expectations[1] by c.10%.

Optima has continued to make strong progress against its strategic objectives and medium-term targets of £200 million revenue and £40 million adjusted EBITDA. The recent acquisition of PAM, which completed on 26 March 2026, positions the enlarged Group to capitalise on the growing market opportunity, whilst benefiting from significant operational and cost synergies which will help Optima achieve its medium-term EBITDA target.

The previously disclosed procurement matter has now been settled. Other operating income of £2.3 million was recognised in H1 FY26, and a further £2.4 million has been recognised in H2 FY26.

A full trading update will be made later in Q2 2026.

Jonathan Thomas, Chief Executive Officer, said: "Optima's strong financial performance in H2, ahead of market expectations, reflects the consistent progress we have continued to make against our strategic objectives. The recent transformational acquisition of PAM has further solidified Optima's position in the attractive and growing occupational health market. We look forward to increasing our presence in our core markets, alongside seeking new opportunities, as we continue to accelerate growth."

 

Enquiries

Optima Health

Jonathan Thomas, CEO

Heidi Giles, CFO

 

+44(0)3300085113

media@OptimaHealth.co.uk

Panmure Liberum Limited

Nominated Adviser and Corporate Broker

Emma Earl / Will Goode/ Mark Rogers

Rupert Dearden

 

+44 (0)20 3100 2000

 

Cavendish Capital Markets

Joint Broker

Geoff Nash/Ben Jeynes/George Lawson

Julian Morse/Michael Johnson/Nigel Birks

 

+ 44 (0)20 7220 0500

ICR Healthcare

UK Financial PR Adviser

Mary-Jane Elliott / Angela Gray / Lindsey Neville

optimahealth@icrinc.com

 

 

About Optima Health

Optima Health is the UK's leading provider of occupational health and wellbeing services, delivering clinically led, technology-driven solutions to organisations across the public and private sectors. With a team of more than 2,000 including 1,250 clinicians, Optima Health supports millions of employees and operates from a network of more than 50 clinics nationwide.

 In addition to its core UK market, Optima Health also operates in Ireland under Optima Health Ireland, providing occupational health services to clients nationwide.

 

For more information visit www.optimahealth.co.uk

 


[1] FY26 adjusted EBITDA market consensus £18.1 million

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUBVVRNRUSARR
Date   Source Headline
13th Sep 20107:00 amRNSOPT wins $4.8m from US Department of Energy
9th Sep 20107:00 amRNS1st Quarter Results
7th Sep 20107:00 amRNSOPT to present at global investment conference
3rd Sep 20107:00 amRNSNotice of Annual Meeting
2nd Sep 20107:00 amRNSNotice of Q1 results and audio webcast
4th Aug 20107:01 amRNSOPT signs agreement for Oregon wave energy project
29th Jul 201011:00 amRNSOPT receives UK funding award
19th Jul 20107:00 amRNSDirector/PDMR Shareholding
13th Jul 20107:00 amRNSFinal Results
6th Jul 20107:00 amRNSNotice of Results
17th Jun 20107:00 amRNSOPT appoints new Vice President of Operations
2nd Jun 20107:00 amRNSOPT appoints new Chief Financial Officer
11th May 20107:00 amRNSRockhouse Mountain Energy wave power project
20th Apr 20107:00 amRNSExecutive Chairman adopts 10b5-1 trading plan
12th Apr 20107:00 amRNSOPT awarded $1.5m for higher output PowerBuoy
12th Mar 20107:00 amRNSOPT third quarter and nine month results
5th Mar 20107:00 amRNSNotice of Results
3rd Mar 20107:00 amRNSOPT receives EUR 2.2m EC grant for Spanish project
2nd Feb 20107:00 amRNSDirector's Dealing
1st Feb 20104:48 pmRNSOPT deploys Hawaii PowerBuoy and wins funding
18th Jan 20107:00 amRNSOPT announces new CEO
10th Dec 20097:00 amRNSOPT 2Q10 Results
8th Dec 20097:00 amRNSOPT executes MoU with State of Oregon
4th Dec 20097:00 amRNSOPT selects OIW to build wave energy device
3rd Dec 20099:29 amRNSOPT to announce Q2 results and host audio webcast
1st Dec 20097:00 amRNSOPT managerial appointment
6th Nov 20094:33 pmRNSOPT Australian project wins A$66.5m award
2nd Nov 20097:00 amRNSOPT completes successful trials of USP
19th Oct 20092:55 pmRNSDirector's Dealing
14th Oct 20097:00 amRNSDirector's Dealing
13th Oct 20097:00 amRNSOPT signs agreement with Lockheed Martin
8th Oct 20097:00 amRNSOPT signs agreement for Japan wave power station
7th Oct 20094:20 pmRNSGrant and Additional Listing of Shares
5th Oct 20095:13 pmRNSGrant of Stock Options and Director's Dealing
5th Oct 20094:12 pmRNSResult of AGM
1st Oct 20097:00 amRNSOPT wins new $2.4 million contract from US Navy
24th Sep 20097:00 amRNSDirector's Dealing
9th Sep 20097:00 amRNS1st Quarter Results
3rd Sep 20094:46 pmRNSOPT Annual Meeting and Proxy Material
2nd Sep 20097:00 amRNSOPT to announce Q1 results and host audio webcast
20th Jul 20097:00 amRNSDirectors' Dealings
15th Jul 20099:30 amRNSOPT deepens commitment to Wave Hub
14th Jul 20097:00 amRNSFinal Results
7th Jul 20095:30 pmRNSNotice of results and audio webcast
11th Jun 20097:00 amRNSOPT achieves major milestones with PB150 PowerBuoy
8th Jun 20092:28 pmRNSOPT appoints CEO for UK and Europe
7th May 20097:00 amRNSGeorge Taylor Receives Major Award
16th Apr 20097:00 amRNSDirector's Dealing
3rd Apr 20093:54 pmRNSOPT Appoints Two New Directors
1st Apr 20097:00 amRNSOPT Receives Additional Funding for Hawaii Project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.